Back
iShares iBonds Oct 2033 Term TIPS ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison
Sell
17
IBIJ
iShares iBonds Oct 2033 Term TIPS ETF
Last Price:
$25.89
Seasonality Move:
1.5%
Buy
78
TVTX
Travere Therapeutics, Inc.
Last Price:
$39.6600
Seasonality Move:
33.23%
Sell
17
iShares iBonds Oct 2033 Term TIPS ETF (IBIJ)
is a Sell
Is iShares iBonds Oct 2033 Term TIPS ETF a Buy, Sell or Hold?
-
The current iShares iBonds Oct 2033 Term TIPS ETF [IBIJ] share price is $25.89. The Score for IBIJ is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
IBIJ is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
78
Travere Therapeutics, Inc. (TVTX)
is a Buy
Is Travere Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Travere Therapeutics, Inc. [TVTX] share price is $39.6400. The Score for TVTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IBIJ Stock Price Chart
What is iShares iBonds Oct 2033 Term TIPS ETF's stock price today?
-
The iShares iBonds Oct 2033 Term TIPS ETF share price today is $25.89Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IBIJ is experiencing slight selling pressure.
TVTX Stock Price Chart
What is Travere Therapeutics, Inc.'s stock price today?
-
The Travere Therapeutics, Inc. share price today is $39.6400Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight selling pressure.
IBIJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 35.27 | Sell |
| Chaikin Money Flow: | -5501 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.02 - 26.32) | Sell |
| Bollinger Bands (100): | (26.07 - 26.41) | Sell |
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.28 | Buy |
| Relative Strength Index (14 RSI): | 66.31 | Buy |
| Chaikin Money Flow: | -583105 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.9202 - 36.9202) | Buy |
| Bollinger Bands (100): | (20.9405 - 34.5405) | Buy |
IBIJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.02 | Sell |
| 20-day SMA: | 26.15 | Sell |
| 50-day SMA: | 26.21 | Sell |
| 200-day SMA: | 25.98 | Sell |
| 8-day EMA: | 25.99 | Sell |
| 20-day EMA: | 26.09 | Sell |
| 50-day EMA: | 26.17 | Sell |
| 200-day EMA: | 26.01 | Sell |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.31 | Buy |
| 20-day SMA: | 35.4 | Buy |
| 50-day SMA: | 33.69 | Buy |
| 200-day SMA: | 22.3 | Buy |
| 8-day EMA: | 30.99 | Buy |
| 20-day EMA: | 18.54 | Buy |
| 50-day EMA: | 8.93 | Buy |
| 200-day EMA: | 2.46 | Buy |
iShares iBonds Oct 2033 Term TIPS ETF Earnings Growth & IBIJ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.
iShares iBonds Oct 2033 Term TIPS ETF Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Travere Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||